Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)
PHASE2RecruitingINTERVENTIONAL
Enrollment
240
Participants
Timeline
Start Date
April 19, 2024
Primary Completion Date
December 9, 2027
Study Completion Date
December 9, 2027
Conditions
Oropharyngeal NeoplasmsRobotic Surgery and/or RadiotherapyLymphoscintigraphy